2021 CMSC Annual Meeting

Tag: (4)F. Hoffmann-La Roche Ltd

Poster-Quality of Life and Outcomes

Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS

Background: Multiple sclerosis (MS) is a chronic progressive disease, affecting a broad range of important functions. In order to...

Read More

Poster-Disease-modifying Therapy

Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis with Suboptimal Response to Prior Disease-Modifying Therapies: Data from the CASTING Study

Background: Patients with relapsing-remitting multiple sclerosis (RRMS) often experience disease activity despite receiving a...

Read More